Read + Share
Tsakmaklis A, Farowski F, Zenner R, Lesker TR, et al. TIGIT(+) NK cells in combination with specific gut microbiota features predict
response to checkpoint inhibitor therapy in melanoma patients. BMC Cancer 2023;23:1160.
PMID: 38017389
|
 |
|
Tsakmaklis A, Farowski F, Zenner R, Lesker TR, et al. TIGIT(+) NK cells in combination with specific gut microbiota features predict
response to checkpoint inhibitor therapy in melanoma patients. BMC Cancer 2023;23:1160.
PMID: 38017389
|
|
|
|